论文部分内容阅读
目的:分析探讨左氧氟沙星三联疗法与阿莫西林三联疗法治疗消化性溃疡的临床疗效。方法:选取2010年8月至2015年9月于该院就诊的消化性溃疡患者共80例,按随机数字表法将所有患者分为两组,治疗组40例,采用左氧氟沙星三联疗法,对照组40例,采用阿莫西林三联疗法,对比两组患者临床治疗效果。结果:治疗组患者治疗总有效率高于对照组,组间对比具有显著性差异(P<0.05),治疗后两组患者的不良反应发生率无明显差异(P>0.05)。结论:使用左氧氟沙星三联疗法治疗消化性溃疡疗效显著,安全性高,值得临床推广。
Objective: To investigate the clinical efficacy of levofloxacin triple therapy and amoxicillin triple therapy in the treatment of peptic ulcer. Methods: A total of 80 patients with peptic ulcer were selected from August 2010 to September 2015 in our hospital. All patients were divided into two groups according to random number table method. The treatment group was 40 cases. The levofloxacin triple therapy and the control group 40 cases, using amoxicillin triple therapy, compared the clinical efficacy of two groups of patients. Results: The total effective rate of the treatment group was higher than that of the control group, with significant difference between the two groups (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups after treatment (P> 0.05). Conclusion: Levofloxacin triple therapy for peptic ulcer significant effect, high safety, worthy of clinical promotion.